Table 4.
The significance of the association of TNF-α with versus without individual clinical manifestations and pathergy reaction.
| TNF-α levels (pg/mL) in patients with | TNF-α levels (pg/mL) in patients without | |||||
|---|---|---|---|---|---|---|
| Manifestations | No. of patients | Median | (Range) | Median | (Range) | P-values |
| Oral ulcer | 31 | 70 | (15–228) | 20 | (15–150) | P = .00* |
| Genital ulcer | 23 | 54 | (17–228) | 21 | (15–228) | P = .00* |
| Ocular lesion | 18 | 99 | (30–228) | 21 | (15–180) | P = .00* |
| Vascular lesion | 37 | 84 | (15–228) | 21 | (15–145) | P = .00* |
| Arthritis/arthralgia | 25 | 38 | (15–228) | 28 | (15–228) | P = .49 |
| EN/PPE | 31 | 45 | (15–228) | 22 | (15–228) | P = .086 |
| (+) pathergy | 35 | 45 | (15–228) | 21 | (15–228) | P = .00* |
P* < .05 by Mann-Whitney U test (statistically significant with versus without clinical manifestations).
Data are presented as median values and their individual ranges within parentheses.